Medicine Grand Rounds: Novel therapies in cardiac amyloidosis 9/25/18

Medicine Grand Rounds: Novel therapies in cardiac amyloidosis 9/25/18

The Science of Cardiac Amyloidosis - Pathophysiology and ‘red flags’Подробнее

The Science of Cardiac Amyloidosis - Pathophysiology and ‘red flags’

Emory Cardiology Grand Rounds 4-23-2018Подробнее

Emory Cardiology Grand Rounds 4-23-2018

Cardiac Amyloidosis Mayo Clinic Grand RoundsПодробнее

Cardiac Amyloidosis Mayo Clinic Grand Rounds

Cardiac AmyloidosisПодробнее

Cardiac Amyloidosis

Cardiac Amyloidosis - Grand Rounds HHSПодробнее

Cardiac Amyloidosis - Grand Rounds HHS

Mythbusters: Cardiac Amyloidosis with Amrut Ambardekar, MDПодробнее

Mythbusters: Cardiac Amyloidosis with Amrut Ambardekar, MD

Phenotyping HFpEF: The Case for Cardiac AmyloidosisПодробнее

Phenotyping HFpEF: The Case for Cardiac Amyloidosis

Cardiac Amyloidosis - Treatment #17Подробнее

Cardiac Amyloidosis - Treatment #17

Cardiac Amyloidosis: Update on Diagnosis and TreatmentПодробнее

Cardiac Amyloidosis: Update on Diagnosis and Treatment

Cardiology Grand Rounds - February 15, 2024Подробнее

Cardiology Grand Rounds - February 15, 2024

Cardiac AmyloidosisПодробнее

Cardiac Amyloidosis

Emerging treatment landscape for Cardiac AmyloidosisПодробнее

Emerging treatment landscape for Cardiac Amyloidosis

10/15/24 Medicine Grand Rounds - Dr. BokhariПодробнее

10/15/24 Medicine Grand Rounds - Dr. Bokhari

Sascha Goonewardena, M.D., CVM Grand Rounds, "Lipoprotein(a): ASCVD Risk and Novel Therapeutics"Подробнее

Sascha Goonewardena, M.D., CVM Grand Rounds, 'Lipoprotein(a): ASCVD Risk and Novel Therapeutics'

Cardiac Amyloidosis: What Every Cardiologist Needs to Know - Mayo Clinic CV Grand RoundsПодробнее

Cardiac Amyloidosis: What Every Cardiologist Needs to Know - Mayo Clinic CV Grand Rounds